These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

354 related articles for article (PubMed ID: 22076870)

  • 1. Prefrontal alterations in Parkinson's disease with levodopa-induced dyskinesia during fMRI motor task.
    Cerasa A; Pugliese P; Messina D; Morelli M; Gioia MC; Salsone M; Novellino F; Nicoletti G; Arabia G; Quattrone A
    Mov Disord; 2012 Mar; 27(3):364-71. PubMed ID: 22076870
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased prefrontal volume in PD with levodopa-induced dyskinesias: a voxel-based morphometry study.
    Cerasa A; Messina D; Pugliese P; Morelli M; Lanza P; Salsone M; Novellino F; Nicoletti G; Arabia G; Quattrone A
    Mov Disord; 2011 Apr; 26(5):807-12. PubMed ID: 21384430
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dopaminergic modulation of cognitive interference after pharmacological washout in Parkinson's disease.
    Fera F; Nicoletti G; Cerasa A; Romeo N; Gallo O; Gioia MC; Arabia G; Pugliese P; Zappia M; Quattrone A
    Brain Res Bull; 2007 Sep; 74(1-3):75-83. PubMed ID: 17683792
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Age at onset influences neurodegenerative processes underlying PD with levodopa-induced dyskinesias.
    Cerasa A; Salsone M; Morelli M; Pugliese P; Arabia G; Gioia CM; Novellino F; Quattrone A
    Parkinsonism Relat Disord; 2013 Oct; 19(10):883-8. PubMed ID: 23769805
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Levodopa influences striatal activity but does not affect cortical hyper-activity in Parkinson's disease.
    Martinu K; Degroot C; Madjar C; Strafella AP; Monchi O
    Eur J Neurosci; 2012 Feb; 35(4):572-83. PubMed ID: 22304628
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A network centred on the inferior frontal cortex is critically involved in levodopa-induced dyskinesias.
    Cerasa A; Koch G; Donzuso G; Mangone G; Morelli M; Brusa L; Stampanoni Bassi M; Ponzo V; Picazio S; Passamonti L; Salsone M; Augimeri A; Caltagirone C; Quattrone A
    Brain; 2015 Feb; 138(Pt 2):414-27. PubMed ID: 25414038
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alterations in opioid receptor binding in Parkinson's disease patients with levodopa-induced dyskinesias.
    Piccini P; Weeks RA; Brooks DJ
    Ann Neurol; 1997 Nov; 42(5):720-6. PubMed ID: 9392571
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes of functional connectivity of the motor network in the resting state in Parkinson's disease.
    Wu T; Wang L; Chen Y; Zhao C; Li K; Chan P
    Neurosci Lett; 2009 Aug; 460(1):6-10. PubMed ID: 19463891
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Resting-state connectivity predicts levodopa-induced dyskinesias in Parkinson's disease.
    Herz DM; Haagensen BN; Nielsen SH; Madsen KH; Løkkegaard A; Siebner HR
    Mov Disord; 2016 Apr; 31(4):521-9. PubMed ID: 26954295
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is executive control used to compensate for involuntary movements in levodopa-induced dyskinesia?
    Aron AR; Obeso J
    Mov Disord; 2012 Mar; 27(3):339-40. PubMed ID: 22411844
    [No Abstract]   [Full Text] [Related]  

  • 11. Levodopa-sensitive, dynamic changes in effective connectivity during simultaneous movements in Parkinson's disease.
    Palmer SJ; Eigenraam L; Hoque T; McCaig RG; Troiano A; McKeown MJ
    Neuroscience; 2009 Jan; 158(2):693-704. PubMed ID: 18722512
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Motor cortex plasticity in Parkinson's disease and levodopa-induced dyskinesias.
    Morgante F; Espay AJ; Gunraj C; Lang AE; Chen R
    Brain; 2006 Apr; 129(Pt 4):1059-69. PubMed ID: 16476674
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Abnormal bidirectional plasticity-like effects in Parkinson's disease.
    Huang YZ; Rothwell JC; Lu CS; Chuang WL; Chen RS
    Brain; 2011 Aug; 134(Pt 8):2312-20. PubMed ID: 21742734
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Involvement of the subthalamic nucleus in impulse control disorders associated with Parkinson's disease.
    Rodriguez-Oroz MC; López-Azcárate J; Garcia-Garcia D; Alegre M; Toledo J; Valencia M; Guridi J; Artieda J; Obeso JA
    Brain; 2011 Jan; 134(Pt 1):36-49. PubMed ID: 21059746
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Non-homogeneous effect of levodopa on inhibitory circuits in Parkinson's disease and dyskinesia.
    Barbin L; Leux C; Sauleau P; Meyniel C; Nguyen JM; Pereon Y; Damier P
    Parkinsonism Relat Disord; 2013 Feb; 19(2):165-70. PubMed ID: 23000298
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pathophysiology of levodopa-induced dyskinesia: potential for new therapies.
    Bezard E; Brotchie JM; Gross CE
    Nat Rev Neurosci; 2001 Aug; 2(8):577-88. PubMed ID: 11484001
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The motor inhibition system in Parkinson's disease with levodopa-induced dyskinesias.
    Cerasa A; Donzuso G; Morelli M; Mangone G; Salsone M; Passamonti L; Augimeri A; Arabia G; Quattrone A
    Mov Disord; 2015 Dec; 30(14):1912-20. PubMed ID: 26275050
    [TBL] [Abstract][Full Text] [Related]  

  • 18. AFQ056 treatment of levodopa-induced dyskinesias: results of 2 randomized controlled trials.
    Berg D; Godau J; Trenkwalder C; Eggert K; Csoti I; Storch A; Huber H; Morelli-Canelo M; Stamelou M; Ries V; Wolz M; Schneider C; Di Paolo T; Gasparini F; Hariry S; Vandemeulebroecke M; Abi-Saab W; Cooke K; Johns D; Gomez-Mancilla B
    Mov Disord; 2011 Jun; 26(7):1243-50. PubMed ID: 21484867
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantifying drug-induced dyskinesias in the arms using digitised spiral-drawing tasks.
    Liu X; Carroll CB; Wang SY; Zajicek J; Bain PG
    J Neurosci Methods; 2005 May; 144(1):47-52. PubMed ID: 15848238
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prefrontal thickening in PD with levodopa-induced dyskinesias: new evidence from cortical thickness measurement.
    Cerasa A; Morelli M; Augimeri A; Salsone M; Novellino F; Gioia MC; Arabia G; Quattrone A
    Parkinsonism Relat Disord; 2013 Jan; 19(1):123-5. PubMed ID: 22742954
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.